|
Volumn 53, Issue 2, 2012, Pages 137-144
|
Ministry of Health clinical practice guidelines: Depression
a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
AGOMELATINE;
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE;
DOPAMINE UPTAKE INHIBITOR;
ESCITALOPRAM;
MIRTAZAPINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
VENLAFAXINE;
ARTICLE;
CLINICAL EVALUATION;
CLINICAL GLOBAL IMPRESSION SCALE;
COGNITIVE THERAPY;
DEPRESSION;
DRUG EFFICACY;
DRUG SAFETY;
ELECTROCONVULSIVE THERAPY;
FAMILY THERAPY;
HEALTH CARE ORGANIZATION;
HUMAN;
INSOMNIA;
PRACTICE GUIDELINE;
PREGNANCY;
PSYCHOEDUCATION;
PSYCHOTHERAPY;
SINGAPORE;
ADOLESCENT;
ADULT;
AGED;
ANTIDEPRESSIVE AGENTS;
CHILD;
DEPRESSION;
HUMANS;
PSYCHOTHERAPY;
|
EID: 84863145361
PISSN: 00375675
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (0)
|